{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T23:57:22Z","timestamp":1772927842295,"version":"3.50.1"},"reference-count":41,"publisher":"Keio Journal of Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med.","Keio j. med"],"published-print":{"date-parts":[[2026]]},"DOI":"10.2302\/kjm.2025-0017-oa","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:08:38Z","timestamp":1772748518000},"source":"Crossref","is-referenced-by-count":0,"title":["Ligustilide Attenuates Neuroinflammation and Fibrosis in an Aluminum          Chloride-induced Rat Model of Alzheimer\u2019s Disease via mTOR\/STAT3 Signaling          Inhibition"],"prefix":"10.2302","author":[{"given":"Nizar","family":"Sirag","sequence":"first","affiliation":[{"name":"Department of Natural Products and Alternative Medicine, Faculty of              Pharmacy, University of Tabuk, Tabuk, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassabelrasoul","family":"Elfadil","sequence":"additional","affiliation":[{"name":"Department of Natural Products and Alternative Medicine, Faculty of              Pharmacy, University of Tabuk, Tabuk, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abduallh J","family":"Ghabban","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi              Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmajeed M","family":"Alasiri","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi              Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtisam R","family":"Alnasser","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi              Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hibah S","family":"Bedaiwi","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi              Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadeem F","family":"Alharbi","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi              Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha J","family":"Almarwani","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi              Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar M","family":"Aljohani","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi              Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan M.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Delta              University for Science and Technology, Gamasa City, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed M H","family":"Al-gayyar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Mansoura University,              Mansoura, Egypt"},{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of              Tabuk, Tabuk, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Salama","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmacy, University of Tabuk,              Tabuk, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. 2023 Alzheimer\u2019s disease facts and figures.          Alzheimers Dement 2023; 19: 1598\u20131695. PMID:36918389          https:\/\/doi.org\/10.1002\/alz.13016","DOI":"10.1002\/alz.13016"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q:          Alzheimer\u2019s Disease: Epidemiology and Clinical Progression. Neurol Ther 2022; 11: 553\u2013569.          PMID:35286590 https:\/\/doi.org\/10.1007\/s40120-022-00338-8","DOI":"10.1007\/s40120-022-00338-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Masurkar PP, Chatterjee S, Sherer JT, Chen H,          Johnson ML, Aparasu RR: Risk of Serious Adverse Events Associated With Individual          Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort          Study. Drugs Aging 2022; 39: 453\u2013465. PMID:35666463          https:\/\/doi.org\/10.1007\/s40266-022-00944-z","DOI":"10.1007\/s40266-022-00944-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tang BC, Wang YT, Ren J: Basic information about          memantine and its treatment of Alzheimer\u2019s disease and other clinical applications. Ibrain          2023; 9: 340\u2013348. PMID:37786758 https:\/\/doi.org\/10.1002\/ibra.12098","DOI":"10.1002\/ibra.12098"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Calsolaro V, Femminella GD, Rogani S, Esposito S,          Franchi R, Okoye C, Rengo G, Monzani F: Behavioral and Psychological Symptoms in Dementia          (BPSD) and the Use of Antipsychotics. Pharmaceuticals (Basel) 2021; 14: 246. PMID:33803277          https:\/\/doi.org\/10.3390\/ph14030246","DOI":"10.3390\/ph14030246"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Huang LK, Kuan YC, Lin HW, Hu CJ: Clinical trials          of new drugs for Alzheimer disease: a 2020\u20132023 update. J Biomed Sci 2023; 30: 83.          PMID:37784171 https:\/\/doi.org\/10.1186\/s12929-023-00976-6","DOI":"10.1186\/s12929-023-00976-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Alshehri AF, Khodier AE, Al-Gayyar MM: Antitumor          Activity of Ligustilide Against Ehrlich Solid Carcinoma in Rats via Inhibition of          Proliferation and Activation of Autophagy. Cureus 2023; 15: e40499. PMID:37333043          https:\/\/doi.org\/10.7759\/cureus.40499","DOI":"10.7759\/cureus.40499"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zhang Q, Zhang X, Yang B, Li Y, Sun XH, Li X, Sui          P, Wang YB, Tian SY, Wang CY: Ligustilide\u2010loaded liposome ameliorates mitochondrial          impairments and improves cognitive function via the PKA \/ AKAP1 signaling pathway in a          mouse model of Alzheimer\u2019s disease. CNS Neurosci Ther 2024; 30: e14460. PMID:37718506          https:\/\/doi.org\/10.1111\/cns.14460","DOI":"10.1111\/cns.14460"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kuang X, Zhou HJ, Thorne AH, Chen XN, Li LJ, Du          JR: Neuroprotective Effect of Ligustilide through Induction of \u03b1-Secretase Processing of          Both APP and Klotho in a Mouse Model of Alzheimer\u2019s Disease. Front Aging Neurosci 2017; 9:          353. PMID:29163135 https:\/\/doi.org\/10.3389\/fnagi.2017.00353","DOI":"10.3389\/fnagi.2017.00353"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Samman WA, Selim SM, El Fayoumi HM, El-Sayed NM,          Mehanna ET, Hazem RM: Dapagliflozin Ameliorates Cognitive Impairment in          Aluminum-Chloride-Induced Alzheimer\u2019s Disease via Modulation of AMPK\/mTOR, Oxidative          Stress and Glucose Metabolism. Pharmaceuticals (Basel) 2023; 16: 753. PMID:37242536          https:\/\/doi.org\/10.3390\/ph16050753","DOI":"10.3390\/ph16050753"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hamdan AM, Al-Gayyar MM, Shams ME, Alshaman US,          Prabahar K, Bagalagel A, Diri R, Noor AO, Almasri D: Thymoquinone therapy remediates          elevated brain tissue inflammatory mediators induced by chronic administration of food          preservatives. Sci Rep 2019; 9: 7026. PMID:31065039          https:\/\/doi.org\/10.1038\/s41598-019-43568-x","DOI":"10.1038\/s41598-019-43568-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hassan HM, Alatawi NM, Bagalagel A, Diri R, Noor          A, Almasri D, Bakhsh HT, Kutbi HI, Ashy N, Al-Gayyar MM: Genistein ameliorated          experimentally induced gastric ulcer in rats via inhibiting gastric tissues fibrosis by          modulating Wnt\/\u03b2-catenin\/TGF-\u03b2\/PKB pathway. Redox Rep 2023; 28: 2218679. PMID:37260037          https:\/\/doi.org\/10.1080\/13510002.2023.2218679","DOI":"10.1080\/13510002.2023.2218679"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Elsherbiny NM, Naime M, Ahmad S, Elsherbini AM,          Mohammad S, Fulzele S, El-Remessy AB, Al-Gayyar MM, Eissa LA, El-Shishtawy MM, Han G,          White R, Haroldo TF, Liou GI: Potential roles of adenosine deaminase-2 in diabetic          retinopathy. Biochem Biophys Res Commun 2013; 436: 355\u2013361. PMID:23685153          https:\/\/doi.org\/10.1016\/j.bbrc.2013.05.023","DOI":"10.1016\/j.bbrc.2013.05.023"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Alharbi TS, Alshammari ZS, Alanzi ZN, Althobaiti          F, Elewa MA, Hashem KS, Al-Gayyar MM: Therapeutic effects of genistein in experimentally          induced ulcerative colitis in rats via affecting mitochondrial biogenesis. Mol Cell          Biochem 2024; 479: 431\u2013444. PMID:37084167          https:\/\/doi.org\/10.1007\/s11010-023-04746-8","DOI":"10.1007\/s11010-023-04746-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu JT:          The Epidemiology of Alzheimer\u2019s Disease Modifiable Risk Factors and Prevention. J Prev          Alzheimers Dis 2021; 8: 313\u2013321. PMID:34101789          https:\/\/doi.org\/10.14283\/jpad.2021.15","DOI":"10.14283\/jpad.2021.15"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kandimalla R, Vallamkondu J, Corgiat EB, Gill KD:          Understanding Aspects of Aluminum Exposure in A lzheimer\u2019s Disease Development. Brain          Pathol 2016; 26: 139\u2013154. PMID:26494454 https:\/\/doi.org\/10.1111\/bpa.12333","DOI":"10.1111\/bpa.12333"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hampel H, Hardy J, Blennow K, Chen C, Perry G,          Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L,          Cummings JL, Vergallo A: The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease. Mol Psychiatry          2021; 26: 5481\u20135503. PMID:34456336          https:\/\/doi.org\/10.1038\/s41380-021-01249-0","DOI":"10.1038\/s41380-021-01249-0"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gulisano W, Maugeri D, Baltrons MA, F\u00e0 M, Amato          A, Palmeri A, D\u2019Adamio L, Grassi C, Devanand DP, Honig LS, Puzzo D, Arancio O: Role of          Amyloid-\u03b2 and Tau Proteins in Alzheimer\u2019s Disease: Confuting the Amyloid Cascade. J          Alzheimers Dis 2018; 64(s1): S611\u2013S631. PMID:29865055          https:\/\/doi.org\/10.3233\/JAD-179935","DOI":"10.3233\/JAD-179935"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pluta R, Ulamek-Koziol M: (2020) Tau          Protein-Targeted Therapies in Alzheimer\u2019s Disease: Current State and Future Perspectives.          In: Huang X (ed) Alzheimer\u2019s Disease: Drug Discovery. Brisbane (AU).          doi:https:\/\/doi.org\/10.36255\/exonpublications.alzheimersdisease.2020.ch4.","DOI":"10.36255\/exonpublications.alzheimersdisease.2020.ch4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Xie PL, Zheng MY, Han R, Chen WX, Mao JH:          Pharmacological mTOR inhibitors in ameliorating Alzheimer\u2019s disease: current review and          perspectives. Front Pharmacol 2024; 15: 1366061. PMID:38873415          https:\/\/doi.org\/10.3389\/fphar.2024.1366061","DOI":"10.3389\/fphar.2024.1366061"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gourmaud S, Stewart DA, Irwin DJ, Roberts N,          Barbour AJ, Eberwine G, O\u2019Brien WT, Vassar R, Talos DM, Jensen FE: The role of mTORC1          activation in seizure-induced exacerbation of Alzheimer\u2019s disease. Brain 2022; 145:          324\u2013339. PMID:34264340 https:\/\/doi.org\/10.1093\/brain\/awab268","DOI":"10.1093\/brain\/awab268"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Morris G, Berk M, Maes M, Puri BK: Could          Alzheimer\u2019s Disease Originate in the Periphery and If So How So? Mol Neurobiol 2019; 56:          406\u2013434. PMID:29705945 https:\/\/doi.org\/10.1007\/s12035-018-1092-y","DOI":"10.1007\/s12035-018-1092-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kasembeli MM, Bharadwaj U, Robinson P, Tweardy          DJ: Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its          Targeting for Treatment. Int J Mol Sci 2018; 19: 2299. PMID:30081609          https:\/\/doi.org\/10.3390\/ijms19082299","DOI":"10.3390\/ijms19082299"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Antar SA, Ashour NA, Marawan ME, Al-Karmalawy AA:          Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation          with Oxidative Stress, Immunity, and Inflammation. Int J Mol Sci 2023; 24: 4004.          PMID:36835428 https:\/\/doi.org\/10.3390\/ijms24044004","DOI":"10.3390\/ijms24044004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Marchetti B, Tirolo C, L\u2019Episcopo F, Caniglia S,          Testa N, Smith JA, Pluchino S, Serapide MF: Parkinson\u2019s disease, aging and adult          neurogenesis: Wnt\/\u03b2\u2010catenin signalling as the key to unlock the mystery of endogenous          brain repair. Aging Cell 2020; 19: e13101. PMID:32050297          https:\/\/doi.org\/10.1111\/acel.13101","DOI":"10.1111\/acel.13101"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sun J, Zhou X, Wu J, Xiao R, Chen Y, Lu Y, Lang          H: Ligustilide enhances hippocampal neural stem cells activation to restore cognitive          function in the context of postoperative cognitive dysfunction. Eur J Neurosci 2021; 54:          5000\u20135015. PMID:34192824 https:\/\/doi.org\/10.1111\/ejn.15363","DOI":"10.1111\/ejn.15363"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Lu Y, Niu L, Shen F, Yang W, Xie Y, Li S, Jiang          M, Bai G: Ligustilide attenuates airway remodeling in COPD mice by covalently binding to          MH2 domain of Smad3 in pulmonary epithelium, disrupting the Smad3\u2010SARA interaction.          Phytother Res 2023; 37: 717\u2013730. PMID:36216328          https:\/\/doi.org\/10.1002\/ptr.7655","DOI":"10.1002\/ptr.7655"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Cao Y, Dong Z, Yang D, Ma X, Wang X: Alleviation          of glucolipotoxicity-incurred cardiomyocyte dysfunction by Z-ligustilide involves in the          suppression of oxidative insult, inflammation and fibrosis. Chem Phys Lipids 2021; 241:          105138. PMID:34547276 https:\/\/doi.org\/10.1016\/j.chemphyslip.2021.105138","DOI":"10.1016\/j.chemphyslip.2021.105138"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Garc\u00eda-Dom\u00ednguez M: The Role of TNF-\u03b1 in          Neuropathic Pain: An Immunotherapeutic Perspective. Life (Basel) 2025; 15: 785.          PMID:40430212 https:\/\/doi.org\/10.3390\/life15050785","DOI":"10.3390\/life15050785"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Judd JM, Jasbi P, Winslow W, Serrano GE, Beach          TG, Klein-Seetharaman J, Velazquez R: Inflammation and the pathological progression of          Alzheimer\u2019s disease are associated with low circulating choline levels. Acta Neuropathol          2023; 146: 565\u2013583. PMID:37548694          https:\/\/doi.org\/10.1007\/s00401-023-02616-7","DOI":"10.1007\/s00401-023-02616-7"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Sivamaruthi BS, Raghani N, Chorawala M,          Bhattacharya S, Prajapati BG, Elossaily GM, Chaiyasut C: NF-\u03baB Pathway and Its Inhibitors:          A Promising Frontier in the Management of Alzheimer\u2019s Disease. Biomedicines 2023; 11:          2587. PMID:37761028 https:\/\/doi.org\/10.3390\/biomedicines11092587","DOI":"10.3390\/biomedicines11092587"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Han J, Zhang Z, Zhang P, Yu Q, Cheng Q, Lu Z,          Zong S: The roles of microglia and astrocytes in neuroinflammation of Alzheimer\u2019s disease.          Front Neurosci 2025; 19: 1575453. PMID:40400619          https:\/\/doi.org\/10.3389\/fnins.2025.1575453","DOI":"10.3389\/fnins.2025.1575453"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Alexopoulou L, Irla M: Toll-like receptors (TLRs)          in the trained immunity era. eLife 2025; 14: e106443. PMID:40891672          https:\/\/doi.org\/10.7554\/eLife.106443","DOI":"10.7554\/eLife.106443"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Yang J, Wise L, Fukuchi K: TLR4 Cross-Talk With          NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer\u2019s Disease. Front Immunol          2020; 11: 724. PMID:32391019 https:\/\/doi.org\/10.3389\/fimmu.2020.00724","DOI":"10.3389\/fimmu.2020.00724"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Li Y, Chen X, Zhou M, Feng S, Peng X, Wang Y:          Microglial TLR4\/NLRP3 Inflammasome Signaling in Alzheimer\u2019s Disease. J Alzheimers Dis          2024; 97: 75\u201388. PMID:38043010 https:\/\/doi.org\/10.3233\/JAD-230273","DOI":"10.3233\/JAD-230273"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kuang X, Wang LF, Yu L, Li YJ, Wang YN, He Q,          Chen C, Du JR: Ligustilide ameliorates neuroinflammation and brain injury in focal          cerebral ischemia\/reperfusion rats: involvement of inhibition of TLR4\/peroxiredoxin 6          signaling. Free Radic Biol Med 2014; 71: 165\u2013175. PMID:24681253          https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.03.028","DOI":"10.1016\/j.freeradbiomed.2014.03.028"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Luo S, Gong J, Cao X, Liu S: Ligustilide          modulates oxidative stress, apoptosis, and immunity to avoid pathological damages in          bleomycin induced pulmonary fibrosis rats via inactivating TLR4\/MyD88\/NF-KB P65. Ann          Transl Med 2020; 8: 931. PMID:32953731          https:\/\/doi.org\/10.21037\/atm-20-4233","DOI":"10.21037\/atm-20-4233"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Yang HX, Jiang XL, Zuo RM, Wu YL, Nan JX, Lian          LH: Targeting RXFP1 by Ligustilide: A novel therapeutic approach for alcoholic hepatic          steatosis. Int Immunopharmacol 2024; 127: 111460. PMID:38157696          https:\/\/doi.org\/10.1016\/j.intimp.2023.111460","DOI":"10.1016\/j.intimp.2023.111460"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Zhang Y, Zhang Y, Han Y, Tian Y, Wu P, Xin A, Wei          X, Shi Y, Zhang Z, Su G, Shi Y, Liu J: Pharmacokinetics, tissue distribution, and safety          evaluation of a ligustilide derivative (LIGc). J Pharm Biomed Anal 2020; 182: 113140.          PMID:32036300 https:\/\/doi.org\/10.1016\/j.jpba.2020.113140","DOI":"10.1016\/j.jpba.2020.113140"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Chao WW, Kuo YH, Li WC, Lin BF: The production of          nitric oxide and prostaglandin E2 in peritoneal macrophages is inhibited by Andrographis          paniculata, Angelica sinensis and Morus alba ethyl acetate fractions. J Ethnopharmacol          2009; 122: 68\u201375. PMID:19111919 https:\/\/doi.org\/10.1016\/j.jep.2008.11.029","DOI":"10.1016\/j.jep.2008.11.029"},{"key":"41","unstructured":"41. Cheng SQ, Lv GH, Liang SX, Wang Y, Xu YC, Zhao          ZZ: [Determination of ligustilide for quality assessment of Ligusticum chuanxiong].          Zhongguo Zhongyao Zazhi 2006; 31: 1143\u20131146. PMID:17048579"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/advpub\/0\/advpub_2025-0017-OA\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:13:46Z","timestamp":1772856826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/advpub\/0\/advpub_2025-0017-OA\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":41,"URL":"https:\/\/doi.org\/10.2302\/kjm.2025-0017-oa","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025-0017-OA"}}